MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Polyrizon Ltd. - Ordinary Shares (NQ:PLRZ)

15.94 +0.27 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 98,688
Open 15.57
Bid (Size) 15.71 (100)
Ask (Size) 16.09 (1,300)
Prev. Close 15.67
Today's Range 15.27 - 16.40
52wk Range 2.880 - 2,235.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX™ Allergy Blocker
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet
From Polyrizon Ltd.
Via GlobeNewswire

Performance

YTD
+25.0%
+25.0%
1 Month
+95.8%
+95.8%
3 Month
+143.7%
+143.7%
6 Month
+83.2%
+83.2%
1 Year
-99.3%
-99.3%

More News

Read More
News headline image
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Announces New Pre-Clinical Results: PL-14 Demonstrates Significant Allergen-Blocking Performance Compared to a Standard Comparator
From Polyrizon Ltd.
Via GlobeNewswire
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
News headline image
As Flu Surge Continues, Polyrizon's Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Polyrizon Completes FDA Pre-Submission Meeting for PL-14 Allergy Blocker Nasal Spray
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Top movers analysis in the middle of the day on 2025-12-05: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
News headline image
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential
Via AB Newswire
Topics Artificial Intelligence Death
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Gapping stocks in Thursday's session ↗
Via Chartmill
News headline image
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
From Lab to Global Impact: Polyrizon's Journey to Potentially Redefining Next-Generation Nasal Protection
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill

Frequently Asked Questions

Is Polyrizon Ltd. - Ordinary Shares publicly traded?
Yes, Polyrizon Ltd. - Ordinary Shares is publicly traded.
What exchange does Polyrizon Ltd. - Ordinary Shares trade on?
Polyrizon Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Polyrizon Ltd. - Ordinary Shares?
The ticker symbol for Polyrizon Ltd. - Ordinary Shares is PLRZ on the Nasdaq Stock Market
What is the current price of Polyrizon Ltd. - Ordinary Shares?
The current price of Polyrizon Ltd. - Ordinary Shares is 15.94
When was Polyrizon Ltd. - Ordinary Shares last traded?
The last trade of Polyrizon Ltd. - Ordinary Shares was at 01/23/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story